Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Claritev Corporation

CTEVNYSE
Healthcare
Medical - Healthcare Information Services
$16.89
$0.87(5.43%)
U.S. Market opens in 15h 7m

Claritev Corporation Fundamental Analysis

Claritev Corporation (CTEV) shows weak financial fundamentals with a PE ratio of -0.97, profit margin of -29.45%, and ROE of 3.78%. The company generates $1.0B in annual revenue with weak year-over-year growth of -3.21%.

Key Strengths

PEG Ratio-0.06

Areas of Concern

ROE3.78%
Operating Margin4.67%
Current Ratio0.86
We analyze CTEV's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 268.0/100 based on profitability, valuation, growth, and balance sheet metrics. The A grade reflects excellent fundamentals and strong overall stability.

Fundamental Health Score

A
268.0/100

We analyze CTEV's fundamental strength across five key dimensions:

Efficiency Score

Weak

CTEV struggles to generate sufficient returns from assets.

ROA > 10%
-5.82%

Valuation Score

Excellent

CTEV trades at attractive valuation levels.

PE < 25
-0.97
PEG Ratio < 2
-0.06

Growth Score

Weak

CTEV faces weak or negative growth trends.

Revenue Growth > 5%
-3.21%
EPS Growth > 10%
-16.91%

Financial Health Score

Moderate

CTEV shows balanced financial health with some risks.

Debt/Equity < 1
-26.64
Current Ratio > 1
0.86

Profitability Score

Weak

CTEV struggles to sustain strong margins.

ROE > 15%
3.78%
Net Margin ≥ 15%
-29.45%
Positive Free Cash Flow
No

Key Financial Metrics

Is CTEV Expensive or Cheap?

P/E Ratio

CTEV trades at -0.97 times earnings. This suggests potential undervaluation.

-0.97

PEG Ratio

When adjusting for growth, CTEV's PEG of -0.06 indicates potential undervaluation.

-0.06

Price to Book

The market values Claritev Corporation at -1.58 times its book value. This may indicate undervaluation.

-1.58

EV/EBITDA

Enterprise value stands at -9.12 times EBITDA. This is generally considered low.

-9.12

How Well Does CTEV Make Money?

Net Profit Margin

For every $100 in sales, Claritev Corporation keeps $-29.45 as profit after all expenses.

-29.45%

Operating Margin

Core operations generate 4.67 in profit for every $100 in revenue, before interest and taxes.

4.67%

ROE

Management delivers $3.78 in profit for every $100 of shareholder equity.

3.78%

ROA

Claritev Corporation generates $-5.82 in profit for every $100 in assets, demonstrating efficient asset deployment.

-5.82%

Following the Money - Real Cash Generation

Operating Cash Flow

Claritev Corporation produces operating cash flow of $118.16M, showing steady but balanced cash generation.

$118.16M

Free Cash Flow

Claritev Corporation generates weak or negative free cash flow of $-12.36M, restricting financial flexibility.

$-12.36M

FCF Per Share

Each share generates $-0.75 in free cash annually.

$-0.75

FCF Yield

CTEV converts -4.43% of its market value into free cash.

-4.43%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.97

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.06

vs 25 benchmark

P/B Ratio

Price to book value ratio

-1.58

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.29

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-26.64

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.86

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

3.78

vs 25 benchmark

ROA

Return on assets percentage

-0.06

vs 25 benchmark

ROCE

Return on capital employed

0.010

vs 25 benchmark

How CTEV Stacks Against Its Sector Peers

MetricCTEV ValueSector AveragePerformance
P/E Ratio-0.9728.25 Better (Cheaper)
ROE378.01%780.00% Weak
Net Margin-29.45%-20122.00% (disorted) Weak
Debt/Equity-26.640.30 Strong (Low Leverage)
Current Ratio0.864.66 Weak Liquidity
ROA-5.82%-14687.00% (disorted) Weak

CTEV outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Claritev Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

61.24%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

-28965.56%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-35.54%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ